GenScript Biotech Expands cGMP Manufacturing for Gene and Cell Therapy in Zhenjiang Facility
China-based GenScript Biotech Corporation (HKG: 1548) has announced the expansion of its current Good Manufacturing...
HKG: 1548
GenScript’s Legend Biotech Files Type II Variation Application for Carvykti with EMA
China-based Contract Research Organization (CRO) GenScript Biotech Corporation (HKG: 1548) has announced that its subsidiary,...
GenScript Biotech’s Legend Biotech Secures Private Placement with Hillhouse Investment
China-based Contract Research Organization (CRO) GenScript Biotech Corporation (HKG: 1548) has revealed that its subsidiary,...
GenScipt Biotech Corp. Expands Oligonucleotide and Peptide Manufacturing in Zhenjiang
China-based Contract Development and Manufacturing Organization (CDMO) GenScipt Biotech Corp. (HKG: 1548) has revealed the...
Luye Pharma’s Boan Biotechnology Partners with GenScript on GenCircle dsDNA Development
Shandong Boan Biotechnology Co., Ltd, a controlling subsidiary of China-based Luye Pharma Group (HKG: 2186),...
GenScript Biotech’s Subsidiary Legend Biotech Announces Positive CAR-T Therapy Results
China-based Contract Research Organization (CRO) GenScript Biotech Corporation (HKG: 1548) has announced that its subsidiary,...
GenScript’s CAR-T Therapy Carvykti Achieves $55M in Sales, Awaits China Approval
China-based Contract Research Organization (CRO) GenScript Biotech Corporation (HKG: 1548) has announced that sales of...
TG ImmunoPharma Gains FDA Approval for Phase I Study of Anti-PVRIG Antibody
China-based TG ImmunoPharma Co., Ltd has announced receiving the go-ahead from the US FDA to...
GenScript’s Legend Biotech Reports USD 55M in Carvykti Sales
China-based Contract Research Organization (CRO) GenScript Biotech Corporation (HKG: 1548) has revealed that sales of...
GenScript Biotech Sues Former CSO Fan Xiaohu for Trade Secret Infringement
Hong Kong-based Contract Research Organization (CRO) GenScript Biotech Corporation (HKG: 1548) has sued its former...
GenScript’s Legend Biotech Appoints Three New Directors to Board
Hong Kong-based Contract Research Organization (CRO) GenScript Biotech Corporation (HKG: 1548) announced that its subsidiary...
GenScript Biotech’s Legend Biotech Terminates LB1901 CAR-T Phase I Trial
Hong Kong-based GenScript Biotech Corporation (HKG: 1548) announced that its subsidiary Legend Biotech Corporation (NASDAQ:...
GenScript Biotech’s ProBio Subsidiary Receives USD 37.25M Investment from Zhenjiang Gaoxin
Hong Kong-based Contract Research Organization (CRO) GenScript Biotech Corporation (HKG: 1548) announced that Zhenjiang Gaoxin...
Genscript’s CAR-T Therapy JNJ-4528 Demonstrates 100% Effective Rate in Long-Term Myeloma Study
Genscript Biotech Corporation (HKG: 1548), a leading China-based Contract Development and Manufacturing Organization (CDMO), has...